Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
about
Subversion of innate defenses by the interplay between DENV and pre-existing enhancing antibodies: TLRs signaling collapseHepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasionHepatitis B virus regulatory HBx protein binds to adaptor protein IPS-1 and inhibits the activation of beta interferonImmunological functions of liver sinusoidal endothelial cellsCrosstalk between innate and adaptive immunity in hepatitis B virus infectionToll-like receptors in pathophysiology of liver diseasesCurrent progress in the development of therapeutic vaccines for chronic hepatitis B virus infectionThe potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinomaCharacterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging AlphavirusesSelective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapyDevelopment of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinasesNatural killer cell activation contributes to hepatitis B viral control in a mouse model.Tickling the TLR7 to cure viral hepatitis.Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions.Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function.Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-β in cultured hepatoma cells.Toll-like receptors in the pathogenesis of alcoholic liver disease.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysToll-like receptor 3 in liver diseases.Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.Small interfering RNAs induce target-independent inhibition of tumor growth and vasculature remodeling in a mouse model of hepatocellular carcinomaLiver immunology.Changes in innate and permissive immune responses after hbv transgenic mouse vaccination and long-term-siRNA treatment [corrected].Cancer-derived immunoglobulin G promotes LPS-induced proinflammatory cytokine production via binding to TLR4 in cervical cancer cellsToll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.A336C/A336T/T337C variations in HBV core gene and spontaneous hepatitis B e antigen loss in chronic hepatitis B patientsSTING agonists induce an innate antiviral immune response against hepatitis B virus.Susceptibility of different hepatitis B virus isolates to interferon-alpha in a mouse model based on hydrodynamic injectionSaturated Fatty Acid inhibits viral replication in chronic hepatitis B virus infection with nonalcoholic Fatty liver disease by toll-like receptor 4-mediated innate immune response.Downregulation of toll-like receptor 4 induces suppressive effects on hepatitis B virus-related hepatocellular carcinoma via ERK1/2 signaling.Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.Toll-like receptors in liver fibrosis: cellular crosstalk and mechanismsInnate immune recognition of hepatitis B virus.MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer.Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigenMolecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan.Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.Design of therapeutic vaccines: hepatitis B as an example.
P2860
Q21144516-EEB2DA0C-B0C0-4AAE-8D04-A340917F7111Q24293039-70888CED-9ED4-4C77-8F5A-DADE6ED9AB65Q24306639-B2FA9876-F5D5-4A1C-B001-EEB001C85BE3Q26753027-19A928CD-9127-4E75-9667-AF6D9997F803Q26771142-4E06744D-2339-4FF6-AD6D-31F5E9FC1EF0Q28070077-368A5B94-195F-4EBC-8CD0-5CB1639E2DA6Q28076279-17449509-C675-4D6B-AE2E-3054AEEE4D61Q28392224-F136F873-5ADF-442B-8A1C-206A064AFA5BQ28551420-6872482B-391B-4C23-A77E-B9FED7D928D3Q28728766-146E6169-3462-4153-AC28-5766E739DA3FQ31121156-4CC6231D-75F8-4449-9E70-7FCA4E051AD9Q33670723-A0460993-E365-4682-A950-8E896F031C51Q33690260-F03F54C6-9B9A-4117-830B-2BEB7A40BF7EQ33794995-715E35CC-6A36-4567-A5F6-CD999F1F6BCCQ33796676-3AEFB20B-643F-437D-A03D-521036B0616CQ33988856-28EC6606-DBFF-4591-9E39-FDB0EE1C6265Q34106192-00557747-84FF-4F97-9781-886CA0821933Q34137297-6694E517-8C63-43A8-8E41-6BD0D57382CDQ34170010-6EFEBDBF-2A81-4CF7-B50E-A12EDA14A452Q34262302-31F5FD37-35DA-4B2F-BF92-89DED3E2B9E2Q34321742-860A7F01-0BF7-4674-BFF0-6FCC3B436F76Q34358256-73A25926-4C06-4ECB-ACA9-8FA94DB49AB3Q34359990-E0726095-F4B3-4DBE-BECF-A65CDF11D3FFQ34614372-6DBF0EE5-9428-4188-A3A4-08FDF31BB514Q34654601-677A4F58-7B84-415C-B6FD-10807CA21AD3Q35008279-07DFA1B3-05EE-400E-9B5B-2917F0C3F985Q35053121-4FE2CBD6-7BF6-4F85-846F-AA2118DF3498Q35105855-B17E6CDC-C83E-45F6-BAE1-173FD974E59CQ35117727-3F195776-3B09-47C7-9783-B716A77F69A0Q35671662-F3BA2012-9068-4B56-926C-FB71012CC837Q35826547-D01BAC9D-9936-401C-BA79-1DCE4BEAE253Q35839139-1308F58B-A6DB-4486-A9CB-9F4125BB604BQ35977675-273C4F78-2C8F-4E72-A9C1-04903777375FQ36080441-2694A5A3-07D8-41C9-A3B9-42DAFBEC36A1Q36240450-E8BB07AB-2F87-4B3C-85FE-B70E67DCA8CEQ36782388-B3E68D59-DA43-4E28-B29E-BFD9F1D83E2FQ36845647-24BB4595-3366-4A1A-B7A5-D6A7EA8FD804Q36988372-C9DCA824-84B8-4CEF-9485-49F40D781A9DQ37195244-B99A588D-B03D-4A07-A80F-0ABAA18E4649Q37274697-D6251FDC-9CBF-4BCC-909F-AA1C1C98591E
P2860
Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice
description
im Dezember 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2007
@uk
name
Toll-like receptor-mediated co ...... arenchymal liver cells in mice
@en
Toll-like receptor-mediated co ...... arenchymal liver cells in mice
@nl
type
label
Toll-like receptor-mediated co ...... arenchymal liver cells in mice
@en
Toll-like receptor-mediated co ...... arenchymal liver cells in mice
@nl
prefLabel
Toll-like receptor-mediated co ...... arenchymal liver cells in mice
@en
Toll-like receptor-mediated co ...... arenchymal liver cells in mice
@nl
P2093
P2860
P50
P356
P1433
P1476
Toll-like receptor-mediated co ...... arenchymal liver cells in mice
@en
P2093
Agnes Szczeponek
Frank Krux
Martin Trippler
Michael Roggendorf
P2860
P304
P356
10.1002/HEP.21897
P407
P577
2007-12-01T00:00:00Z